Use of baxdrostat was associated with a reduction in office-measured systolic blood pressure of around 9 mm Hg at 12 weeks and reductions in 24-hour ambulatory systolic blood pressure of around 15 mm Hg in the BaxHTN trial.
New horizons of cardiotherapySince the introduction of the first implantable stimulator and defibrillator (ICD), cardiological science has advanced far. ICDs are highly effective, but their main disadvantage is the complications associated with the electrodes. To avoid the need for venous access and complications caused by transvenous electrodes, a fully subcutaneous ICD system (pc-ICD) was developed.
The relationship between low‑density lipoprotein cholesterol, the apolipoprotein B ratio, and sarcopeniaThe ratio of low‑density lipoprotein cholesterol to apolipoprotein B (LDL‑C/ApoB) (LDL-C/ApoB), which reflects the cholesterol content in an atherogenic lipoprotein particle, may serve as a new biomarker for the risk of sarcopenia. Scientists conducted a study based on data from the largest American representative survey (NHANES).
General Anesthesia Ups Heart Failure Risk After Valve SurgeryTranscatheter aortic valve replacement (TAVR) patients who received general anesthesia had a higher incidence of heart failure at 1 year than those who received nongeneral anesthesia.